As SARS-CoV-2 continues to evolve, there is a continued need for research and testing technologies that are better suited to dealing with these novel viruses.
Twist’s hybrid capture system and custom SARS-CoV-2 NGS Assay – RUO, combined with Biotia’s COVID-DX software, represents a powerful new advancement in viral surveillance research.Download this application focus to learn about:
- The end-to-end SARS-CoV-2 NGS assay workflow
- Benefits of hybrid-capture technology and COVID-DX software
- How target enrichment leads to more even coverage across the entire genome